ProfileGDS5678 / 1433447_x_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 98% 98% 98% 98% 98% 98% 97% 98% 98% 98% 98% 98% 98% 98% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 110.058198
GSM967853U87-EV human glioblastoma xenograft - Control 210.116798
GSM967854U87-EV human glioblastoma xenograft - Control 310.101498
GSM967855U87-EV human glioblastoma xenograft - Control 410.203998
GSM967856U87-EV human glioblastoma xenograft - Control 510.002198
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 19.8170298
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 29.4280297
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 39.7351498
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 49.8611498
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 110.10398
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 29.7649798
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 310.15398
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 49.9950798
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 510.106698